Thirty-five MNHS projects receive 2025 NHMRC Ideas Grant funding
MNHS researchers received 35 National Health and Medical Research Council (NHMRC) Ideas Grants for 2025, worth over $42 million and announced yesterday by the Minister for Health and Aged Care, the Honourable Mark Butler MP.
The Ideas Grant scheme's objective is to support innovative and creative research projects addressing a specific question in any health and medical research area from discovery to implementation for researchers at all career stages.
Professor Edwina McGlinn from the Australian Regenerative Medicine Institute received $1.7million for a project focused on utero corrections of craniofacial malformations, Professor Roger Daley from Monash Biomedicine Discovery Institute received $1.027 million for a project focused on novel and therapeutically actionable signalling axis in poor prognosis cancers and Dr Ting Xia from Eastern Health Clinical School received $800,000 for a project focused on transforming opioid poisoning surveillance through novel technologies.
Congratulations to all of our successful recipients.
Other funded projects include:
Lead researcher | School/Institute | Project | Funding |
Professor Andrew Forbes | School of Public Health and Preventative Medicine | Advancing cluster randomised trials to the next generation: Development of multi-domain platform cluster trial designs and machine learning methods for estimating personalised treatment effects | $896,433.90 |
Associate Professor Nadine Andrew | School of Translational Medicine | Novel methods to enhance the use of routinely collected linked data for the evaluation of government policies related to healthy ageing | $1,407,622.40 |
Professor John Boyce | Monash Biomedicine Discovery Institute | Harnessing type VI secretion system lysins for fighting bacterial superbugs | $857,585.00 |
Professor Roger Daly | Monash Biomedicine Discovery Institute | A novel, therapeutically actionable, signalling axis in poor prognosis cancers | $1,027,696.00 |
Dr Gonzalo del Monte Nieto | Australian Regenerative Medicine Institute | Exploring the proliferation potential of trabecular myocardium | $1,645,318.00 |
Associate Professor Ross Dickins | School of Translational Medicine | PD-L1 checkpoint agonist therapies in autoimmunity and transplantation | $727,929.12 |
Associate Professor Ross Dickins | School of Translational Medicine | Lineage-directed differentiation therapy of acute myeloid leukaemia | $1,020,869.50 |
Associate Professor Andrew Ellisdon | Monash Biomedicine Discovery Institute | Molecular mechanisms underlying mTORC1 lysosomal regulation in cell growth and disease | $1,352,546.50 |
Associate Professor Daniel Gough | School of Clinical Sciences at Monash Health Hudson | Rewiring the innate immune response to improve lung adenocarcinoma treatment. | $1,504,295.00 |
Professor Christoph Hagemeyer | School of Translational Medicine | A first-in-class anti-thrombotic therapy targeting blood flow activated von Willebrand Factor | $1,116,640.00 |
Professor Elizabeth Hartland | School of Clinical Sciences at Monash Health Hudson | Cell stress and cell intrinsic immune responses to intracellular bacteria | $1,818,840.00 |
Dr Danika Hill | School of Translational Medicine | Total recall: Exploiting human immune memory for smarter and safer Strep A vaccine strategies | $1,603,676.80 |
Dr Danika Hill | School of Translational Medicine | Super-mAbs for Super-Ags: A novel therapeutic strategy for life-threatening invasive streptococcal disease. | $1,221,058.50 |
Associate Professor Robin Hobbs | School of Clinical Sciences at Monash Health Hudson | Male germline regeneration and fertility restoration after genotoxic damage | $1,667,443.60 |
Adjunct Associate Professor David Spanswick | Monash Biomedicine Discovery Institute | Targeting chronic pain: non-pharmacological manipulation of endogenous adenosine | $736,218.40 |
Associate Professor Jan Kaslin | Australian Regenerative Medicine Institute | Regrow with the flow | $899,707.50 |
Dr Terry Kwok | Monash Biomedicine Discovery Institute | Targeting evolution to combat Helicobacter pylori antibiotic resistance | $874,585.00 |
Dr Mitchell Lawrence | Monash Biomedicine Discovery Institute | Early Bipolar Androgen Therapy for Advanced Prostate Cancer | $1,664,813.30 |
Dr Chen Li | Monash Biomedicine Discovery Institute | Unveiling the immunogenicity of the dark immunopeptidome of melanoma | $862,774.00 |
Professor Dena Lyras | Monash Biomedicine Discovery Institute | Understanding host and pathogen adaptations during recovery from C. difficile infection | $1,778,338.75 |
Professor Dena Lyras | Monash Biomedicine Discovery Institute | Investigating gut dysmotility induced by Clostridioides difficile infection | $1,501,643.94 |
Adjunct Associate Professor Ashley Mansell | School of Clinical Sciences at Monash Health - Hudson | The role and therapeutic potential of targeting the NLRP1 inflammasome in mucosal immunity | $988,737.20 |
Professor Edwina McGlinn | Australian Regenerative Medicine Institute | In utero correction of craniofacial malformations | $1,171,374.00 |
Associate Professor Shayanti Mukherjee | School of Clinical Sciences at Monash Health - Hudson | Advancing Pelvic Organ Prolapse Surgical Outcomes with Surface Engineering | $1,393,376.20 |
Dr Nevin John | School of Clinical Sciences at Monash Health | Pregnancy and the multiple sclerosis brain | $1,359,383.39 |
Dr Antonella Papa | Monash Biomedicine Discovery Institute | Targeting the non-canonical protein-phosphatase activity of PTEN for cancer therapy | $1,279,542.00 |
Professor Anton Peleg | School of Translational Medicine | Mechanistic Insights and Therapeutic Targeting of small RNAs in Acinetobacter baumannii | $1,298,648.00 |
Professor Martin Stone | Monash Biomedicine Discovery Institute | Suppression of Treg Recruitment in Cancer Immunotherapy: Tick Evasins as Chemokine-targeted Therapeutics | $1,057,950.00 |
Professor Greg Stuart | Monash Biomedicine Discovery Institute | Investigating Neuronal Check Points Generating Epileptiform Discharges In Human Epileptic Circuits | $879,895.20 |
Professor David Tarlinton | School of Translational Medicine | How environment, competition, and location combine to control plasma cell lifespan | $1,077,080.00 |
Dr Ting Xia | Eastern Health Clinical School | Transforming opioid poisoning surveillance through novel technologies | $862,132.50 |
Professor Naotsugu Tsuchiya | School of Psychological Sciences | Brain signature of loss-of-consciousness across species | $1,111,302.20 |
Professor Stephen Turner | Monash Biomedicine Discovery Institute | Investigating IRF1 as a Pioneering Factor in Shaping Optimal T Cell Immunity | $1,017,252.00 |
Dr Amy Winship | Monash Biomedicine Discovery Institute | Protecting fertility, healthy pregnancy and long-term endocrine function for cancer survivors after immunotherapy | $1,414,313.00 |
Dr Tamara Yawno | School of Clinical Sciences at Monash Health - Hudson | Nanomedicine for preterm brain injury | $1,281,057.00 |
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES